By David Tuller, DrPH Long Covid stories and commentaries seem to be everywhere, too many to keep track of! This week, The Wall Street Journal published an opinion piece about long Covid and ME/CFS that is breathtakingly ill-informed, and more importantly, just wrong. Beyond that, it showed remarkable disrespect for patients and their experiences. (After …
By David Tuller, DrPH In a post earlier this week, I noted some differences in the tenor of the debate over Long Covid in the US and UK. Yesterday, another excellent and in-depth piece on the issues appeared on the domestic front, this time in VICE. The author, Alan Levinovitz, is associate professor of religious …
By David Tuller, DrPH Last week, two major articles on long Covid appeared in well-known US publications, one in the Atlantic, the other in Vox. Like the New York Times Magazine article that ran in January, these stories addressed with nuance the complex and unclear relationship between the varieties of long Covid and the group …
Trial By Error: Biopsychosocial Brigades Seek Traction with Long Covid Read More »
By David Tuller, DrPH Tracie White, a science writer at Stanford University, first stumbled across the story of Whitney Dafoe as an assignment from one of her editors. That initial encounter ultimately turned into The Puzzle Solver: A Scientist’s Desperate Quest to Cure the Illness that Stole His Son, an account that Kirkus called “a …
Trial By Error: A Q-and-A with Tracie White, author of The Puzzle Solver Read More »
Many virology terms are being used these days by people who do not understand their meaning. Included are journalists, medical doctors, scientists, lawyers, and people from all walks of life. In normal times this word mis-usage would be so rare that it would not matter. However, because we are in a viral pandemic that affects …
Understanding virus isolates, variants, and strains Read More »
By David Tuller, DrPH The US government seems to be taking Long COVID seriously. In December, Congress allocated $1.15 billion over four years for research into the issue. This week, Francis Collins, director of the National Institutes of Health, announced the agency’s plans for that funding. (I’ve posted his announcement in full below.) In a …
